glucagon has been researched along with bay-k-8644 in 4 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 2,555 | 0 | 144 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marco, J; Miralles, P; Monge, L; Peiró, E; Silvestre, RA; Villanueva, ML | 1 |
Raue, F; Scherübl, H; Ziegler, R; Zopf, G | 1 |
Bataille, D; Blache, P; Dalle, S; Le Brigand, L; Le-Nguyen, D | 1 |
Gaisano, HY; MacDonald, PE; Salapatek, AM; Wheeler, MB | 1 |
4 other study(ies) available for glucagon and bay-k-8644
Article | Year |
---|---|
In vitro effects of BAY K 8644, a dihydropyridine derivative with hypoglycaemic properties, on hepatic glucose production and pancreatic hormone secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Glucagon; Gluconeogenesis; Glucose; Glycogen; Insulin; Insulin Secretion; Liver; Male; Pancreas; Pancreatic Hormones; Perfusion; Rats; Rats, Inbred Strains; Somatostatin | 1988 |
Calcitonin secretion and cyclic AMP-efflux from C-cells, stimulated by glucagon and either calcium or Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcitonin; Calcium; Carcinoma; Cell Line; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Rats; Thyroid Gland; Thyroid Neoplasms; Tumor Cells, Cultured | 1989 |
Miniglucagon: a local regulator of islet physiology.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Peptides | 1998 |
Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Barium; Calcium Channel Agonists; Cell Line; Cyclic AMP; Electric Conductivity; Gene Deletion; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Mutagenesis; Peptide Fragments; Protein Precursors; Rats; Receptors, Glucagon; Structure-Activity Relationship; Transfection | 1999 |